• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Hematology

Latest News

CAR T in NHL | Image Credit: © LASZLO-stock.adobe.com
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL

April 3rd 2025

In this comparative analysis, patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) received bridging therapy via radiation or systemic treatment while their chimeric antigen receptor T-cell therapy (CAR T) was being manufactured.

Targeting GPRC5D Holds Promise in Multiple Myeloma
Targeting GPRC5D Holds Promise in Multiple Myeloma

April 3rd 2025

Patient and doctor discussing symptoms. | Image credit: Intelligent Horizons - stock.adobe.com.jpeg
PROs Associated With Survival, AEs in Multiple Myeloma

April 3rd 2025

ESA treatment before or early after regular transfusion therapy improved OS In lower-risk MDS, a new study found. | Image credit: MdBabul - stock.adobe.com
ESA Treatment Improves OS in Lower-Risk MDS

March 28th 2025

ASH logo | images: ASH
Amid NIH Cuts, ASH Expands Eligibility for Midcareer Research Awards

March 24th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.